Profile of ipilimumab and its role in the treatment of metastatic melanoma
Sapna P Patel, Scott E WoodmanMelanoma Medical Oncology Department, University of Texas, MD Anderson Cancer Center, Houston, TX, USAAbstract: Melanoma is an immunogenic cancer. However, the ability of the immune system to eradicate melanoma tumors is affected by intrinsic negative regulatory mechani...
Saved in:
Main Authors: | Patel SP (Author), Woodman SE (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2011-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ipilimumab: Melanoma and beyond
by: Vishal Patel, et al.
Published: (2011) -
Body composition is prognostic and predictive of ipilimumab activity in metastatic melanoma
by: Michael P. Chu, et al.
Published: (2020) -
Use of ipilimumab in the treatment of melanoma
by: Acharya UH, et al.
Published: (2013) -
Ipilimumab, a Promising Immunotherapy with Increased Overall Survival in Metastatic Melanoma?
by: Gérald E. Piérard, et al.
Published: (2012) -
A real world example of coverage with evidence development in Australia - ipilimumab for the treatment of metastatic melanoma
by: Hansoo Kim, et al.
Published: (2018)